These effects on insulin’s actions in peripheral organs have been examined in models of obesity and diabetes [5], however; there is little information regarding the effects of an increase in central leptin bioavailability on hepatic insulin sensitivity in non-obese animals. The gene discussed is INS; the disease is obesity due to melanocortin 4 receptor deficiency.